Patheon discussions with Lonza terminated
October 20, 2009 by leonardzehr · Leave a Comment
Lonza Group, a Swiss drugs industry supplier, has withdrawn a $460-million (U.S.) offer to acquire Mississauga-based contract drug manufacturer Patheon (TSX:PTI), citing the opposition of majority shareholder JLL Patheon Holdings, a U.S. private equity company. Earlier this year, Patheon rejected an unsolicited takeover bid from JLL, which holds a 57% stake in Patheon, as being [...]
Listen to BioTuesdays 
